The 5th Annual LabRoots Cancer Research & Oncology Virtual Conference is now On-Demand!
LabRoots invites research professionals, scientists, and clinicians to this premier online conference, making it easier and more cost-effective to learn about recent advances in cancer research. The virtual conference is free to attendees, encouraging worldwide collaboration and connections between colleagues and field experts.
Cancer research has made major advancements in diagnosis, treatments, and the basic understanding of the disease itself. Within the last year, we have seen progress in immunotherapy, treatments involving nanotechnology, advances in targeted and personalized therapeutics and drug development, and a decrease in mortality rates due to a strong focus on learning more about the origination of the disease.
Cancer Research & Oncology 2017 focuses on advancements in prevention, diagnosis and treatment of different cancer types. The world’s thought leaders in cancer research will present their latest discoveries in cancer mechanics and detection as well as clinical aspects such as targeted therapies and novel treatments, all in an international venue conducive to networking.
Our virtual conference allows you to participate in a global setting with no travel or cost to you. You can participate in exactly those parts which you are interested in and be back at your desk or bench in an instant. Virtual events remove time and place restrictions and ensure that everyone who wants to participate can do so. This virtual conference also offers increased reach for the global cancer community with a high degree of interaction through live-streaming video and chat sessions. Attendees can earn free CME and CE Credits.
Topics for this year's virtual conference included:
By participating in this virtual event and watching webcast presentations, you can earn Free Continuing Education (PACE) and/or Continuing Medical Education (CME) credits. To earn educational credits, you must view an entire presentation. Following the presentation you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit.
Use #LRcancer to follow the conversation!
POSTER SUBMISSION GUIDELINES
Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer reviewed. Submission is free.
SUBMIT YOUR ABSTRACT
Enter the following information to this Submission Form:
All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.
If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.
Questions? Email Posters@LabRoots.com
Agilent (www.agilent.com) is a leader in life sciences, clinical research, diagnostics and applied chemical markets. With over 11,000 employees worldwide, the company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling ...See more See less
ATCC is the premier global biological materials resource and standards organization whose mission focuses on the acquisition, authentication, production, preservation, development, and distribution of standard reference microorganisms, cell lines, and other materials. While ...See more See less
Millipore Sigma is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life - from biopharmaceutical therapies to treat cancer or multiple sclerosis ...See more See less
Our goal is simply to help researchers gain a better understanding of proteins and their role in disease. We develop and commercialize proprietary systems and consumables for protein analysis that ultimately help reveal new insights into the true nature of proteins. Our goal is ...See more See less
As an innovator in reagents and tools, our purpose is to serve life science researchers globally to achieve their mission, faster. Providing the research and clinical communities with tools and scientific support, we offer highly validated biological binders and assays to address ...See more See less
NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications ...See more See less
Getson & Schatz, P.C. is an experienced Immigration Law Firm conveniently located at 230 South Broad Street, Suite 1001, Philadelphia, PA 19102 (Corner of Broad and Locust Streets). Our immigration lawyers represent individuals, families, scientific researchers, and corporations ...See more See less
Oxford Nanopore Technologies has developed the world's first and only nanopore DNA sequencer, the MinION. The MinION is a portable, real time, long-read, low cost device that has been designed to bring easy biological analyses to anyone, whether in scientific research, education ...See more See less
QIAGEN N.V., a Netherlands holding company, is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular information. Sample technologies are used to isolate and process DNA, RNA and proteins from biological ...See more See less
Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare. AATI develops, manufactures and markets high-throughput, fully-automated nucleic ...See more See less
For 60 years The Baker Company has been at the forefront of engineering, testing and production of reliable laboratory contamination control equipment. Recognized as the industry pioneer, The Baker Company maintains an unparalleled passion for helping our customers advance ...See more See less
Bio-Rad Laboratories (NYSE: BIO and BIOb) continues to play a leading role in the advancement of scientific discovery by offering a broad range of innovative tools and services to the life science research and clinical diagnostics markets. Founded in 1952, Bio-Rad has a global ...See more See less
Dharmacon continues to be the industry leader in the field of RNA chemistry, RNAi biology and high-throughput screening, and partners with the RNAi screening community through participation in the RNAi Global Initiative. With Dharmacon, you get access to the largest and most ...See more See less
Diagenode is a leading global provider of complete solutions for epigenetics research, biological sample preparation, and diagnostics assays based in Liège, Belgium and Denville, NJ, USA. The company has developed both shearing solutions for a number of applications as well as a ...See more See less
Illumina is transforming human health as the global leader in sequencing and array-based technologies. Illumina's flexible and scalable sequencing systems support and enable a wide range of single-cell sequencing applications, from low-throughput deep interrogation of rare cell ...See more See less
Envigo provides the broadest range of research models and related services to the pharmaceutical and biotechnology industries, government, academia, and other life science organizations. As the largest organization that is solely dedicated to providing research models and related ...See more See less
ImmunoChemistry Technologies, LLC provides quality laboratory services and research reagents. As a contract service laboratory, ICT specializes in custom immunoassay development, manufacturing, conjugation, lyophilization, and consulting services. ICT is focused on ELISA ...See more See less
LI-COR Biosciences offers imaging systems, analysis software, and IRDye® infrared dye reagents for quantitative protein and small animal imaging. LI-COR provides the complete solution for Western blots with its Odyssey® Infrared Imaging Systems, C-DiGit® Blot Scanner, analysis ...See more See less
At Paragon Genomics, we develop and commercialize rapid, easy-to-use, and ultra-high multiplex PCR-based target enrichment solutions for the Next-Generation Sequencing (NGS) markets. Our proprietary CleanPlex™ background-removing technology enables NGS customers to develop ...See more See less
As a company founded by scientists, Proteintech Group recognises the tireless efforts and sacrifices made by researchers to advance scientific discovery. Proteintech aims to match its' customers' dedication to research by providing high quality, reliable reagents that ...See more See less
Ultivue provides researchers and scientists with multiplex biomarker assays for tissue phenotyping and digital pathology. Ultivue's InSituPlex® technology eliminates the need for assay development and enables scientists to unmask and analyze the true biological context of tissue ...See more See less
Horizon Discovery Group PLC is a world leader in the utilization of gene editing and gene modulation technologies to support the greater understanding of gene function, the genetic drivers behind human disease and the development of molecular, cell and gene therapies to enable ...See more See less
Innova Biosciences are world leading experts in easy-to-use, cutting-edge bioconjugation technologies and services. The Company has the flexibility to support scientists from academia through to commercial manufacturing, developing and supplying reagent products to make science ...See more See less
At Imanis, our expert scientists work to advance the development of tomorrow's medicines by creating top-quality oncolytic viruses and noninvasive reporter gene imaging reagents. At the heart of our imaging science is NIS, the sodium iodide symporter. Our proprietary NIS reporter ...See more See less
GenScript is the leading gene, peptide, protein and antibody research partner for fundamental life science research, translational biomedical research, and early stage pharmaceutical development. Since our establishment in 2002, GenScript has exponentially grown to become a ...See more See less
LabRoots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities.
Conference series welcome to the world largest gathering of the 10th International Conference on Endocrinology will explore on Upswings in the ideas of Endocrinology Management by bringing the international academics, practitioners, and experts together in Chicago, USA from ...See more See less
Manuscriptedit specializes in providing services in Scientific & English editing, proofreading, medical writing, academic writing, formatting and publication support. Within a short span of time, the company has grown rapidly to be counted among the world's leading service ...See more See less
Dr. David M. Albala graduated with a geology degree from Lafayette College in Easton, Pennsylvania. He completed his medical school training at Michigan State University and went on to complete his surgical residency at the Dartmouth-Hitchcock Medical Center. Following this, Dr ...See more See less
Dr. Antonio T. Baines is an Associate Professor in the Department of Biology at North Carolina Central University (NCCU) and an adjunct professor in the Department of Pharmacology in the School of Medicine at the University of North Carolina (UNC) Chapel Hill. He earned a ...See more See less
Dr. Blonder leads the Clinical Proteomics Group at the CRTP/FNL. FNL is a Federally Funded Research and Development Center operated by Leidos Biomedical Research, Inc., for the National Cancer Institute (NCI). In 1978, Dr. Blonder received his M.D. at the Rijeka University ...See more See less
Dr. Rajan T. Gupta, MD, is an Assistant Professor of Radiology in the Division of Abdominal Imaging at Duke University Medical Center, as well as the Director of the Abdominal Imaging Fellowship Program and a Faculty physician in the Duke Cancer Institute. Since 2009, he has been ...See more See less
Fred Russell Kramer is Professor of Microbiology and Molecular Genetics at the New Jersey Medical School, and has been a Principal Investigator at the Public Health Research Institute for the past 25 years. He graduated from the University of Michigan in 1964 and received his ...See more See less
The discovery of proteinaceous disease biomarkers and their clinical validation is critically important for the enablement of molecular diagnostics and ultimately, precision medicine. In spite of the importance of biomarkers, research done in the last two decades has yielded ...See more See less
President & CEO of StressMarq Biosciences Inc., a research reagent company with primary product lines in neurodegenerative diseases and cellular stress based in Victoria (BC), Canada. Successful Senior Scientific Business Executive with demonstrated expertise growing markets ...See more See less
Judd W. Moul is James H. Semans, MD Professor of Surgery, Division of Urologic Surgery, and Director of the Duke Prostate Center, Duke Cancer Institute at Duke University Medical Center. Prior to joining Duke, he was Professor of Surgery at the Uniformed Services University of ...See more See less
Dr. Perkins joined the Melanoma Research Alliance as Chief Science Officer in 2013 where she is responsible for the development and implementation of the MRA's scientific strategy including its research award program and annual Scientific Retreat. Her interests center on ...See more See less
Thomas J. Polascik, M.D. is Professor in the Duke Cancer Institute, the Department of Surgery at the Duke University Medical Center, Durham, NC. Dr. Polascik trained at the Brady Urological Institute, the Johns Hopkins Hospital in Baltimore Maryland. After finishing his residency ...See more See less
|Operating System||Internet Explorer||Firefox||Chrome||Safari|
|Windows 7||IE8+||FF10+||Chrome15+||Windows 8||IE10||FF10+||Chrome15+|
|Mac OS X||FF10+||Chrome15+||Safari5.1+|
- For viewing Webinars:
- For viewing Virtual Events